Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Orchard Therapeutics plc (ORTX) ADR EACH REPR 1 ORD SHS SPON

Sell:$11.43 Buy:$11.48 Change: $0.27 (2.30%)
NASDAQ:0.05%
Market closed |  Prices as at close on 5 December 2019 | Switch to live prices |
Sell:$11.43
Buy:$11.48
Change: $0.27 (2.30%)
Deal now Deal for just £11.95 per trade in a SIPP or Fund and Share Account
Market closed |  Prices as at close on 5 December 2019 | Switch to live prices |
Sell:$11.43
Buy:$11.48
Change: $0.27 (2.30%)
Market closed |  Prices as at close on 5 December 2019 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a SIPP or Fund and Share Account
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Orchard Therapeutics plc, formerly Orchard Rx Ltd, is a commercial-stage, fully-integrated biopharmaceutical company. It is engaged in manufacturing and commercialization of gene and cell therapies, position to provide transformative therapies to patients suffering from a range of rare diseases. The Company is focused on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders and hemoglobinopathies. Its portfolio includes Strimvelis, its commercial-stage gammaretroviral-based product for the treatment of ADA-SCID five lentiviral product candidates in clinical-stage development and several other product candidates in preclinical development. It is developing OTL-101 as an autologous ex vivo lentiviral gene therapy to sustainably treat patients with adenosine deaminase severe combined immunodeficiency (ADA-SCID) through a single administration.

Contact details

Address:
108 Cannon Street
London
EC4N 6EU
United Kingdom
Telephone:
+44 (20) 33846700
Website:
https://www.orchard-tx.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
ORTX
ISIN:
US68570P1012
Market cap:
$1.29 billion
Shares in issue:
180.73 million
Sector:
Biotechnology
Exchange:
NASDAQ
Country:
Great Britain
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel


Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.
Deal now Deal for just £11.95 per trade in a SIPP or Fund and Share Account

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.